Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
Molecules · 2023
DOI: 10.3390/molecules28073063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Simone Vink und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Australia. Hauptthemen laut MEDLINE: Natriuretic Peptides, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Grants Commission, University of Queensland.
Abstract (Originalsprache)
Cardiovascular ailments are a major cause of mortality where over 1.3 billion people suffer from hypertension leading to heart-disease related deaths. Snake venoms possess a broad repertoire of natriuretic peptides with therapeutic potential for treating hypertension, congestive heart failure, and related cardiovascular disease. We now describe several taipan (Oxyuranus microlepidotus) natriuretic peptides TNPa-e which stimulated cGMP production through the natriuretic peptide receptor A (NPR-A) with higher potencies for the rat NPR-A (rNPR-A) over human NPR-A (hNPR-A). TNPc and TNPd were the most potent, demonstrating 100- and 560-fold selectivity for rNPR-A over hNPR-A. In vivo studies found that TNPc decreased diastolic and systolic blood pressure (BP) and increased heart rate (HR) in conscious normotensive rabbits, to a level that was similar to that of human atrial natriuretic peptide (hANP). TNPc also enhanced the bradycardia due to cardiac afferent stimulation (Bezold–Jarisch reflex). This indicated that TNPc possesses the ability to lower blood pressure and facilitate cardiac vagal afferent reflexes but unlike hANP does not produce tachycardia. The 3-dimensional structure of TNPc was well defined within the pharmacophoric disulfide ring, displaying two turn-like regions (RMSD = 1.15 Å). Further, its much greater biological stability together with its selectivity and potency will enhance its usefulness as a biological tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Australia.
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, CH-1211 Geneva, Switzerland.
- Nanoscale Organisation and Dynamics Group, Western Sydney University, Penrith 2759, Australia.
- School of Life and Environmental Sciences, University of Sydney, Sydney 2006, Australia.
- Baker Heart and Diabetes Institute, Melbourne 3004, Australia.
ORCID-Profile: Philip W Kuchel, Paul F Alewood
Förderung
- Australian Research Grants Commission
- University of Queensland
Zitieren
APA
Vink, S., Akondi, K. B., Jin, J., Poth, K., Torres, A. M., Kuchel, P. W., Burke, S. L., Head, G. A., & Alewood, P. F. (2023). Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A. Molecules. https://doi.org/10.3390/molecules28073063
Vancouver
Vink S, Akondi KB, Jin J, Poth K, Torres AM, Kuchel PW, et al. Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A. Molecules. 2023. doi:10.3390/molecules28073063
BibTeX
@article{Vink2023,
author = {Vink, Simone and Akondi, Kalyana Bharati and Jin, Jean and Poth, Kim and Torres, Allan M and Kuchel, Philip W and Burke, Sandra L and Head, Geoffrey A and Alewood, Paul F},
title = {Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28073063}
}
EUVIMED